# A Study of LY3871801 in Healthy Asian and Non-Asian Participants

> **NCT05960851** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 32 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** LY3871801
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05960851
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-08-09
- **Primary completion:** 2023-10-25
- **Final completion:** 2023-10-25
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2024-01-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05960851

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05960851, "A Study of LY3871801 in Healthy Asian and Non-Asian Participants". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05960851. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*